Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Attorney Deal Cites 16 Reasons Why Governor Inslee Should Veto Mandatory MMR Vaccine Bill
  • USA - English

Attorney Deal says: Only two people in the United States have died from measles in the past ten years, while around 108 have died in reaction to the MMR. Many thousands have been sickened. The MMR changes measles from a less harmful childhood disease to a more harmful baby disease, pregnant mother disease, and adult disease. It contains toxic additives. The MMR is not kosher, not halal, not nihil obstat, not vegan, and not non-GMO.


News provided by

James Robert Deal Attorney PLLC

May 08, 2019, 07:29 ET

Share this article

Share toX

Share this article

Share toX

LYNNWOOD, Wash., May 8, 2019 /PRNewswire-PRWeb/ -- Topic: Attorney Deal Cites 16 Reasons Why Governor Inslee Should Veto Mandatory MMR Vaccine Bill
From: James Robert Deal, Attorney
Contact: 425-771-1110, James(at)JamesDeal(dot)com
To: All media
For release: May 8, 2019
Follow links at: http://www.JamesRobertDeal.org/16-reasons-why-governor-inslee-should-veto-mandatory-vaccination-bill

Lynnwood Attorney James Robert Deal releases the following information:

The Washington Legislature recently passed a law which will eliminate philosophical and personal objections to the MMR vaccine, making vaccination with the MMR a precondition in most cases to attending public or private school or daycare. Governor Jay Inslee has not yet signed the bill into law.

Deal offers 16 reasons why Governor Inslee should veto the new MMR vaccination bill:

1) The MMR package insert lists serious adverse reactions which the MMR has caused, including diabetes, arthritis, encephalitis, Guillain-Barre Syndrome, and death. See: http://www.immunize.org/fda. It is wrong to trade one malady for another. The National Vaccine Information Center reports that only two people in the United States have died from measles over the past ten years, while around 108 have died in reaction to the MMR. The MMR does more harm than good.

2) The number of measles deaths has dropped in Western countries. MMR supporters give the MMR credit for this reduction. However, almost all of the reduction occurred before the measles vaccine was introduced. "Vaccination does not account for the impressive declines in mortality seen in the first half of the century." Vaccination reduces the number of overt cases of measles but not the number of deaths from measles.

3) The law is an overreach. The current, small epidemic is a measles epidemic, not a mumps or rubella epidemic. Eliminating informed consent is a serious matter. The law would nullify informed consent as to two diseases which are not epidemic.

4) The MMR is a tri-valent, combo vaccine. It is three in one. There are serious adverse reactions from the MMR, and because it is a combo vaccine, we cannot tell which of the three component is causing the adverse reactions.

Shameless Marketing: I co-broker with other brokers on challenging transactions nationwide. Flat fee payable at closing. https://www.WashingtonAttorneyBroker.com/Helping-Brokers

5) The MMR has never been double blind tested against an inert placebo. It was approved after testing on only 800 people.

6) MMR supporters say that 95% must be vaccinated to stop measles. For several reasons it is mathematically impossible to get to 95%. Protection wears off, which is why boosters are given. In many outbreaks large percentages of those coming down with measles have been fully vaccinated. The vaccine just does not work on some. Adults are not generally re-vaccinated for measles, and so most have lost all immunity. Because it is impossible to reach the 95% level, there is no rational legal basis for mandating the MMR and depriving parents of their right of informed consent.

7) Some cannot be vaccinated because they have autoimmune disorders. However, the MMR itself can cause autoimmune disorders. "One study found that 'a failed cellular immune response to measles vaccine is a potential cause of autoimmunity.'" My son should not be required to be vaccinated in order to protect those children who have an autoimmune disorder because the MMR may cause him to develop his own autoimmune disorder.

8) Measles is mostly harmless to adolescents but especially harmful to babies, to pregnant women, and to adults in general. Ironically, routine vaccination against measles has increased incidence of measles in all three groups. A boy or girl who contracts wild measles as a child is immune for life. When a girl later gets pregnant, she cannot catch measles. And she will pass her immunity into her baby.

On the other hand, girls who are vaccinated as children may have lost their immunity when they later become pregnant. They can catch measles while pregnant and will have no immunity to pass on to their babies. Vaccinating against measles has shifted the population which typically contracts measles, from adolescents who handle measles relatively well, to adults and babies who do not.

9) The MMR does cause autism, as the CDC found in a 2004 study. CDC heads did not like the autism finding, so they held a garbage can party and trashed the offending evidence. In that study autism appeared mostly in black boys. CDC heads eliminated all subjects who had not presented a birth certificate, who were mostly black children. In so doing, they reversed the finding. In 2014 William Thompson, who had been present at the garbage can party, publicly disclosed the fraud. The media has almost completely ignored this story.

10) The Supreme Court, in justifying almost complete immunity for vaccine manufacturers under the Vaccine Injury Act of 1986, has referred to the CDC vaccines as "unavoidably unsafe", explaining that those who take them should know they are taking a risk and are therefore accepting the risk.

11) Vaccine manufacturers are immune from all liability provided they fully disclose all known risks. The MMR package insert discloses the many harms the MMR is known to cause. However, package inserts are almost never shown to parents. In the early years of the Vaccine Injury Act, medical doctors had to obtain signatures from parents indicating informed consent. This took too much of their time, and so the requirement was waived. Disclosure is inadequate, which therefore undermines immunity from liability.

12) There was no provision and no discussion in the Vaccine Injury Act about making any vaccines mandatory. The CDC childhood vaccines are experimental. An experimental vaccine should not be mandatory.

13) MMR components are all grown in cells from aborted fetuses. The MMR contains gelatin from pig bones. It contains bovine cells and recombinant human cells. Thus, the MMR is not kosher, not halal, not nihil obstat, not vegan, and not non-GMO. Religious objections are inevitable, and the state should not be put in the position of deciding religious questions.

14) The Washington Constitution makes education the paramount duty of the state but says little about health. If we are excluding children from school who are not sick with measles, we will be violating their constitutional rights.

15) Pediatricians receive $400 per year for each fully vaccinated child, which is worth $400,000 per year in a practice with 1,000 children. This is why many pediatricians refuse to treat unvaccinated children. These undisclosed kickbacks compromise doctors and explain their unquestioning support of the CDC vaccines.

16) The CDC, FDA, elected representatives, state and county health departments, medical schools, and medical practices all receive generous funding from Big Pharma. TV networks receive enormous fees for pharmaceutical ads. All of these groups should be considered captured and not credible sources of information about vaccine safety. Once a cash flow gets going, it is hard to stop. People are easily convinced by white coats.

Read online and follow links at: http://www.JamesRobertDeal.org/16-reasons-why-governor-inslee-should-veto-mandatory-vaccination-bill

For links to scholarly journals which substantiate Deal's claims, see:

https://www.jamesrobertdeal.org/washington-should-not-mandate-ineffective-and-harmful-cdc-vaccines

https://www.JamesRobertDeal.org/attorneys-viewpoint-vaccinations.

Shameless Marketing: I co-broker with other brokers on challenging transactions nationwide. Flat fee payable at closing. https://www.WashingtonAttorneyBroker.com/Helping-Brokers

Sincerely,
James Robert Deal
Real Estate Attorney & Real Estate Managing Broker
James(at)JamesDeal(dot)com
PO Box 2276 Lynnwood WA 98036
Law Office Line: 425-771-1110
Broker Line: 425-774-6611
KW Everett Office Line: 425-212-2007
Fax: 425-776-8081
I help brokers. Flat fee payable at closing.
WashingtonAttorneyBroker.com/Helping-Brokers
WashingtonAttorneyBroker.com/Seller-Financing
Property search:
JamesRobertDeal.com
Mortgage-Modification-Attorney.com
Fluoride-Class-Action.com/Safewater
JamesRobertDeal.org/Smart-Meters
JamesRobertDeal.org/Attorneys-Viewpoint-Vaccinations
JamesRobertDeal.org/Door-To-Door-Transit

SOURCE James Robert Deal Attorney PLLC

Related Links

https://www.jamesrobertdeal.org

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.